Vancomycin-resistant Enterococci: the clinical effect of a common nosocomial pathogen
- 1 February 1999
- journal article
- review article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 33 (2) , 113-120
- https://doi.org/10.1016/s0732-8893(98)00148-5
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- An outbreak of vancomycin-resistant Enterococcus faecium in liver transplant recipientsLiver Transplantation, 1997
- Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns.Clinical Infectious Diseases, 1997
- Vancomycin Use in a University Medical Center: Comparison With Hospital Infection Control Practices Advisory Committee GuidelinesInfection Control & Hospital Epidemiology, 1996
- Use of Bacitracin Therapy for Infection Due to Vancomycin-Resistant Enterococcus faeciumClinical Infectious Diseases, 1995
- Controlling Vancomycin-Resistant EnterococciInfection Control & Hospital Epidemiology, 1995
- Vancomycin-Resistant Enterococcus faecium Bacteremia: Risk Factors for InfectionClinical Infectious Diseases, 1995
- Characterization of glycopeptide-resistant enterococci from U.S. hospitalsAntimicrobial Agents and Chemotherapy, 1993
- Nosocomial infection with microsphere bedsThe Lancet, 1993
- RP 59500, a new streptogramin highly active against recent isolates of North American staphylococciDiagnostic Microbiology and Infectious Disease, 1993
- Enterococcal Bacteremia: To Treat or Not to Treat, a ReappraisalClinical Infectious Diseases, 1991